Why most weight-loss clinics pick a ready platform over custom development A clinic could build its own telehealth service for GLP-1 therapy, but the cost is hard to justify for groups with 2 to 50 staff clinicians
Food and Drug Administration (FDA) approval for the treatment of type 2 diabetes (Mounjaro ) and for chronic weight management (Zepbound )
Among the aforementioned strategies, antibiotic potentiation is one of the most promising methods
Retatrutide may be worth waiting for only in rare cases: patients who've maximized results on both approved options
Semaglutide is dispensed as either an anti-diabetes or an anti-obesity medication, with Wegovy being an immensely popular weight management strategy
Receptor density in cardiovascular and immune tissues is, however, markedly lower than in the pancreas, and the modest physiological increment in GLP-1 produced by DPP-4 inhibition does not appear sufficient to drive the downstream signaling needed for anti-inflammatory, endothelial, or plaque-modifying effects [13], [14], [28]